JP2008510683A5 - - Google Patents

Download PDF

Info

Publication number
JP2008510683A5
JP2008510683A5 JP2007522011A JP2007522011A JP2008510683A5 JP 2008510683 A5 JP2008510683 A5 JP 2008510683A5 JP 2007522011 A JP2007522011 A JP 2007522011A JP 2007522011 A JP2007522011 A JP 2007522011A JP 2008510683 A5 JP2008510683 A5 JP 2008510683A5
Authority
JP
Japan
Prior art keywords
group
technetium complex
following formula
formula
conr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007522011A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008510683A (ja
JP5557425B2 (ja
Filing date
Publication date
Priority claimed from GBGB0416062.8A external-priority patent/GB0416062D0/en
Application filed filed Critical
Publication of JP2008510683A publication Critical patent/JP2008510683A/ja
Publication of JP2008510683A5 publication Critical patent/JP2008510683A5/ja
Application granted granted Critical
Publication of JP5557425B2 publication Critical patent/JP5557425B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007522011A 2004-07-19 2005-07-19 改良n4キレーターコンジュゲート Expired - Lifetime JP5557425B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0416062.8A GB0416062D0 (en) 2004-07-19 2004-07-19 Improved N4 chelator conjugates
GB0416062.8 2004-07-19
PCT/GB2005/002807 WO2006008496A2 (en) 2004-07-19 2005-07-19 Improved n4 chelator conjugates

Publications (3)

Publication Number Publication Date
JP2008510683A JP2008510683A (ja) 2008-04-10
JP2008510683A5 true JP2008510683A5 (enExample) 2008-09-04
JP5557425B2 JP5557425B2 (ja) 2014-07-23

Family

ID=32893775

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007522011A Expired - Lifetime JP5557425B2 (ja) 2004-07-19 2005-07-19 改良n4キレーターコンジュゲート

Country Status (14)

Country Link
US (1) US7767796B2 (enExample)
EP (1) EP1768708B1 (enExample)
JP (1) JP5557425B2 (enExample)
KR (2) KR20070034064A (enExample)
CN (1) CN101128219B (enExample)
AU (1) AU2005263942B2 (enExample)
BR (1) BRPI0513456A (enExample)
CA (1) CA2573384C (enExample)
ES (1) ES2628935T3 (enExample)
GB (1) GB0416062D0 (enExample)
MX (1) MX2007000744A (enExample)
NO (1) NO20070348L (enExample)
RU (1) RU2360701C2 (enExample)
WO (1) WO2006008496A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI448284B (zh) * 2007-04-24 2014-08-11 Theravance Inc 雙效抗高血壓劑
CN101732736B (zh) * 2009-12-02 2012-04-04 北京师范大学 制备锝-99m标记的DTPA-LSA的药盒及制备方法和应用
GB0922014D0 (en) 2009-12-17 2010-02-03 Ge Healthcare Ltd Novel integrin binders
GB201016206D0 (en) * 2010-09-27 2010-11-10 Ge Healthcare Ltd Apoptosis imaging agents
RU2465011C1 (ru) * 2011-04-27 2012-10-27 Общество с ограниченной ответственностью "ИНТЕРА-МЕД" Радиофармацевтический препарат для диагностики меланомы и ее метастазов
GB201110767D0 (en) 2011-06-24 2011-08-10 Ge Healthcare Ltd Infection imaging
GB201600161D0 (en) * 2016-01-05 2016-02-17 Bayer As Isotope purification method
RU2655392C1 (ru) * 2017-03-02 2018-05-28 Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский Томский политехнический университет" Способ получения комплекса технеция-99м с октреотидом для диагностики нейроэндокринных опухолей
CN112105393A (zh) 2018-05-16 2020-12-18 爱默蕾大学 苯乙烯基苯并噻唑衍生物及在成像中的用途
US20250215027A1 (en) * 2021-08-11 2025-07-03 Cancer Research Technology Limited Diphosphine compounds and complexes

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175343A (en) * 1985-01-14 1992-12-29 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
ATE66469T1 (de) * 1985-01-14 1991-09-15 Neorx Corp Metall-radionuklid markiertes protein fuer diagnose und therapie.
US5242679A (en) * 1985-01-14 1993-09-07 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5053493A (en) * 1987-04-02 1991-10-01 Centocor Cardiovascular Imaging Partners, L.P. Method for labeling antibodies with a metal ion
JPH02504387A (ja) * 1987-04-02 1990-12-13 セントカー・カーデイオバスキユラー・イメージング・パートナーズ・エルピー 金属イオンで抗体を標識付けする方法
US4952393A (en) * 1987-04-02 1990-08-28 The General Hospital Corporation Organ infarct imaging with technetium labelled glucarate
US5489425A (en) * 1987-06-24 1996-02-06 The Dow Chemical Company Functionalized polyamine chelants
US4994560A (en) * 1987-06-24 1991-02-19 The Dow Chemical Company Functionalized polyamine chelants and radioactive rhodium complexes thereof for conjugation to antibodies
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
NO940080L (no) * 1993-01-12 1994-07-13 Sandoz Ag Polypeptider , fremgangsmåte for deres fremstilling og farmasöytiske preparater derav
US5650134A (en) * 1993-01-12 1997-07-22 Novartis Ag (Formerly Sandoz Ltd.) Peptides
CA2232411A1 (en) * 1995-09-18 1997-03-27 Mallinckrodt Medical, Inc. (radio) labelled biotin derivatives
GR1003661B (el) * 2000-05-25 2001-09-05 Εθνικο Κεντρο Ερευνας Φυσικων Επιστημων (Εκεφε) "Δημοκριτος"... ΣΥΝΘΕΣΗ, ΒΙΟΛΟΓΙΚΗ ΚΑΙ ΠΡΟΚΛΙΝΙΚΗ ΑΞΙΟΛΟΓΗΣΗ ΑΝΑΛΟΓΩΝ ΤΗΣ (D-Phe6, Leu-NHEt13, des-Met14)-ΒΟΜΒΕΣΙΝΗΣ (6-14)ΤΡΟΠΟΠΟΙΗΜΕΝΩΝ ΜΕ ΠΑ ΡΑΓΩΓΑ ΤΟΥ 1,4,8,11-ΤΕΤΡΑΑΖΑΕΝΔΕΚΑΝΙΟΥ(1,4,8,11-TETRAAZAUNDECAN E)ΚΑΙ ΕΠΙΣΗΜΑΣΜΕΝΩΝ ΜΕ ΤΕΧΝΗΤΙΟ-99M- ΓΙΑ ΕΦΑΡΜΟΓΗ ΣΤΗΝ ΟΓΚΟΛΟΓ
GB0116815D0 (en) * 2001-07-10 2001-08-29 Nycomed Amersham Plc Improved chelator conjugates
CN1622830A (zh) * 2001-07-10 2005-06-01 安盛药业有限公司 肽基化合物
GB0130305D0 (en) 2001-12-19 2002-02-06 Amersham Plc Compounds for imaging alzheimers disease
US7785566B2 (en) * 2003-11-06 2010-08-31 Ge Healthcare, Inc. Pharmaceutical compounds
US7431914B2 (en) * 2003-11-24 2008-10-07 Ge Healthcare As Contrast agent
CN1925876A (zh) * 2004-03-04 2007-03-07 通用电气医疗集团股份有限公司 用于诊断和治疗的血管紧张素肽类似物和螯合剂的缀合物

Similar Documents

Publication Publication Date Title
JP2004516314A5 (enExample)
JP2013507423A5 (enExample)
NO20021399L (no) Kazolinderivater og deres anvendelse som farmasöyter
EP1862458A3 (en) Therapeutic agents useful for treating pain
WO2007048066A3 (en) Pyrazolo-pyrimidines as casein kinase ii (ck2) modulators
JP2015510886A5 (enExample)
JP2009541289A5 (enExample)
JP2014515406A5 (enExample)
JP2014518882A5 (enExample)
CA2591867A1 (en) Cooling topical patch preparation
JP2006507265A5 (enExample)
JP2012511023A5 (enExample)
DK2041133T3 (da) Derivater af imadazol [1,2-A] pyridine-2-carboxamider, fremstilling deraf og anvendelse deraf i terapeutik
EP2253333A3 (en) Contrast Agents for Myocardial Perfusion Imaging
JP2004525888A5 (enExample)
PE20061319A1 (es) Cristales formados de clorhidrato de {[(2r)-7-(2,6-diclorofenil)-5-fluoro-2-3-dihidro-1-benzofurano-2-il]metil}amina
JP2006523214A5 (enExample)
EP1857459A3 (en) Pyrazolopyrimidine compound and a process for preparing the same
SE0402925D0 (sv) Novel Compounds
RU2000125889A (ru) Замещенные бисиндолималеимиды, предназначенные для ингибирования пролиферации клеток
RU2009140730A (ru) Некоторые аминоалкилглюкозаминидфосфатные производные и их применение
GEP20104964B (en) 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
GEP20104882B (en) Age inhibitors
WO2003051848A3 (en) Imidazolidineacetic acid derivatives
RU2007101515A (ru) Совершенствованные конъюгаты n4 хелатообразующих агентов